VG Life Sciences Inc.
VGLS
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 504.30K | 576.50K | 641.80K | 651.60K | 458.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 644.40K | 739.30K | 801.50K | 541.50K | 798.80K |
| Operating Income | -644.40K | -739.30K | -801.50K | -541.50K | -798.80K |
| Income Before Tax | -1.02M | -1.41M | -1.47M | -433.10K | -1.07M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.02M | -1.41M | -1.47M | -433.10K | -1.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 8.60K | 8.60K | 8.60K | 8.60K | 8.60K |
| Net Income | -1.01M | -1.40M | -1.46M | -424.50K | -1.06M |
| EBIT | -644.40K | -739.30K | -801.50K | -541.50K | -798.80K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | -0.02 | -0.03 | -0.01 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -0.01 | -0.02 |
| EPS Diluted | -0.01 | -0.02 | -0.03 | -0.01 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 85.45M | 66.90M | 51.64M | 38.57M | 28.94M |
| Average Diluted Shares Outstanding | 85.45M | 66.90M | 51.64M | 38.57M | 28.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
